Strides Pharma Science Discontinued
FDA Approved Drugs

Strides Pharma Science Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 103
  • Latest Approval Date Apr 29, 2025
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
227
View
Unclassified
1
View
Discontinued
103
View
OTC
6
View
RX
117
View
Company Overview

Company

Strides Pharma Science Discontinued

Country

India

Website

Visit Website

Email

enquiries@synergice.co

Social Profiles

LinkedIn
Company Snapshot

Strides Pharma Science Discontinued

Strides House, Bilekahalli, Bannerghatta Road, Bangalore – 560076

India

www.synergice.co/ enquiries@synergice.co View on Map
FDA Approved Drug Records ( 103 records )
1982
01 Jan
Discontinued Application: 86366

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

Approval Date

1982-01-01

86366 / 1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Application Number

86366

Product Number

1

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

2025
17 Jan
Discontinued Application: 217241

Drug Name

ACETAMINOPHEN AND IBUPROFEN

Product Number

1

Dosage Form

-

Strength

250MG;125MG

Approval Date

2025-01-17

217241 / 1

Active Ingredient

ACETAMINOPHEN; IBUPROFEN

Application Number

217241

Product Number

1

Dosage Form

-

Strength

250MG;125MG

Approval Date

2025-01-17

Regulatory Status

Discontinued

2018
07 Dec
Discontinued Application: 210011

Drug Name

ALBENDAZOLE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-12-07

210011 / 1

Active Ingredient

ALBENDAZOLE

Application Number

210011

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-12-07

Regulatory Status

Discontinued

2007
11 Jul
Discontinued Application: 77516

Drug Name

AMLODIPINE BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2007-07-11

77516 / 1

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77516

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2007-07-11

Regulatory Status

Discontinued

2007
11 Jul
Discontinued Application: 77516

Drug Name

AMLODIPINE BESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-07-11

77516 / 2

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77516

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-07-11

Regulatory Status

Discontinued

2007
11 Jul
Discontinued Application: 77516

Drug Name

AMLODIPINE BESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-07-11

77516 / 3

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77516

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-07-11

Regulatory Status

Discontinued

2023
21 Dec
Discontinued Application: 217634

Drug Name

ATORVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2023-12-21

217634 / 1

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

217634

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2023-12-21

Regulatory Status

Discontinued

2023
21 Dec
Discontinued Application: 217634

Drug Name

ATORVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-12-21

217634 / 2

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

217634

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-12-21

Regulatory Status

Discontinued

2023
21 Dec
Discontinued Application: 217634

Drug Name

ATORVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-12-21

217634 / 3

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

217634

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-12-21

Regulatory Status

Discontinued

2023
21 Dec
Discontinued Application: 217634

Drug Name

ATORVASTATIN CALCIUM

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2023-12-21

217634 / 4

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

217634

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2023-12-21

Regulatory Status

Discontinued

2022
15 Jul
Discontinued Application: 215772

Drug Name

AZITHROMYCIN

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2022-07-15

215772 / 1

Active Ingredient

AZITHROMYCIN

Application Number

215772

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2022-07-15

Regulatory Status

Discontinued

2022
12 Jul
Discontinued Application: 215773

Drug Name

AZITHROMYCIN

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2022-07-12

215773 / 1

Active Ingredient

AZITHROMYCIN

Application Number

215773

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2022-07-12

Regulatory Status

Discontinued

2020
21 Sep
Discontinued Application: 203647

Drug Name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2020-09-21

203647 / 1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Application Number

203647

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2020-09-21

Regulatory Status

Discontinued

2016
22 Sep
Discontinued Application: 204195

Drug Name

BUTALBITAL, ASPIRIN AND CAFFEINE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2016-09-22

204195 / 1

Active Ingredient

ASPIRIN; BUTALBITAL; CAFFEINE

Application Number

204195

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2016-09-22

Regulatory Status

Discontinued

2015
12 Nov
Discontinued Application: 205513

Drug Name

CARISOPRODOL

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2015-11-12

205513 / 1

Active Ingredient

CARISOPRODOL

Application Number

205513

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2015-11-12

Regulatory Status

Discontinued

2015
12 Nov
Discontinued Application: 205513

Drug Name

CARISOPRODOL

Product Number

2

Dosage Form

-

Strength

350MG

Approval Date

2015-11-12

205513 / 2

Active Ingredient

CARISOPRODOL

Application Number

205513

Product Number

2

Dosage Form

-

Strength

350MG

Approval Date

2015-11-12

Regulatory Status

Discontinued

2025
29 Apr
Discontinued Application: 213127

Drug Name

CELECOXIB

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-04-29

213127 / 1

Active Ingredient

CELECOXIB

Application Number

213127

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-04-29

Regulatory Status

Discontinued

2025
29 Apr
Discontinued Application: 213127

Drug Name

CELECOXIB

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2025-04-29

213127 / 2

Active Ingredient

CELECOXIB

Application Number

213127

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2025-04-29

Regulatory Status

Discontinued

2025
29 Apr
Discontinued Application: 213127

Drug Name

CELECOXIB

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2025-04-29

213127 / 3

Active Ingredient

CELECOXIB

Application Number

213127

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2025-04-29

Regulatory Status

Discontinued

2019
21 Jun
Discontinued Application: 205077

Drug Name

DEXTROAMPHETAMINE SULFATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-06-21

205077 / 1

Active Ingredient

DEXTROAMPHETAMINE SULFATE

Application Number

205077

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-06-21

Regulatory Status

Discontinued

2019
21 Jun
Discontinued Application: 205077

Drug Name

DEXTROAMPHETAMINE SULFATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-06-21

205077 / 2

Active Ingredient

DEXTROAMPHETAMINE SULFATE

Application Number

205077

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-06-21

Regulatory Status

Discontinued

2019
21 Jun
Discontinued Application: 205077

Drug Name

DEXTROAMPHETAMINE SULFATE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2019-06-21

205077 / 3

Active Ingredient

DEXTROAMPHETAMINE SULFATE

Application Number

205077

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2019-06-21

Regulatory Status

Discontinued

2011
31 May
Discontinued Application: 78662

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-31

78662 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

78662

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-31

Regulatory Status

Discontinued

2011
31 May
Discontinued Application: 78662

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-31

78662 / 2

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

78662

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-31

Regulatory Status

Discontinued

2012
08 Jun
Discontinued Application: 202778

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2012-06-08

202778 / 1

Active Ingredient

DOXYCYCLINE

Application Number

202778

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2012-06-08

Regulatory Status

Discontinued

2018
22 Jun
Discontinued Application: 208227

Drug Name

DUTASTERIDE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2018-06-22

208227 / 1

Active Ingredient

DUTASTERIDE

Application Number

208227

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2018-06-22

Regulatory Status

Discontinued

2021
16 Jun
Discontinued Application: 78509

Drug Name

EFAVIRENZ

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2021-06-16

78509 / 1

Active Ingredient

EFAVIRENZ

Application Number

78509

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2021-06-16

Regulatory Status

Discontinued

2018
18 Jun
Discontinued Application: 207536

Drug Name

FLUCYTOSINE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2018-06-18

207536 / 1

Active Ingredient

FLUCYTOSINE

Application Number

207536

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2018-06-18

Regulatory Status

Discontinued

2018
18 Jun
Discontinued Application: 207536

Drug Name

FLUCYTOSINE

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2018-06-18

207536 / 2

Active Ingredient

FLUCYTOSINE

Application Number

207536

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2018-06-18

Regulatory Status

Discontinued

2019
25 Jun
Discontinued Application: 200770

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2019-06-25

200770 / 4

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

200770

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2019-06-25

Regulatory Status

Discontinued

2006
06 Nov
Discontinued Application: 77723

Drug Name

HYDROCODONE

Product Number

3

Dosage Form

-

Strength

5MG;200MG

Approval Date

2006-11-06

77723 / 3

Active Ingredient

HYDROCODONE BITARTRATE; IBUPROFEN

Application Number

77723

Product Number

3

Dosage Form

-

Strength

5MG;200MG

Approval Date

2006-11-06

Regulatory Status

Discontinued

2006
06 Nov
Discontinued Application: 77723

Drug Name

HYDROCODONE BITARTRATE AND IBUPROFEN

Product Number

1

Dosage Form

-

Strength

7.5MG;200MG

Approval Date

2006-11-06

77723 / 1

Active Ingredient

HYDROCODONE BITARTRATE; IBUPROFEN

Application Number

77723

Product Number

1

Dosage Form

-

Strength

7.5MG;200MG

Approval Date

2006-11-06

Regulatory Status

Discontinued

2006
06 Nov
Discontinued Application: 77723

Drug Name

HYDROCODONE BITARTRATE AND IBUPROFEN

Product Number

2

Dosage Form

-

Strength

10MG;200MG

Approval Date

2006-11-06

77723 / 2

Active Ingredient

HYDROCODONE BITARTRATE; IBUPROFEN

Application Number

77723

Product Number

2

Dosage Form

-

Strength

10MG;200MG

Approval Date

2006-11-06

Regulatory Status

Discontinued

2018
29 Jun
Discontinued Application: 206989

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-06-29

206989 / 1

Active Ingredient

IBUPROFEN

Application Number

206989

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-06-29

Regulatory Status

Discontinued

2017
30 May
Discontinued Application: 207052

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2017-05-30

207052 / 1

Active Ingredient

IBUPROFEN

Application Number

207052

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2017-05-30

Regulatory Status

Discontinued

2022
09 Jun
Discontinued Application: 214071

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

50MG/1.25ML

Approval Date

2022-06-09

214071 / 1

Active Ingredient

IBUPROFEN

Application Number

214071

Product Number

1

Dosage Form

-

Strength

50MG/1.25ML

Approval Date

2022-06-09

Regulatory Status

Discontinued

2014
24 Jun
Discontinued Application: 202002

Drug Name

IMIQUIMOD

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2014-06-24

202002 / 1

Active Ingredient

IMIQUIMOD

Application Number

202002

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2014-06-24

Regulatory Status

Discontinued

2019
02 Jul
Discontinued Application: 206410

Drug Name

ITRACONAZOLE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2019-07-02

206410 / 1

Active Ingredient

ITRACONAZOLE

Application Number

206410

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2019-07-02

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78042

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-01-15

78042 / 1

Active Ingredient

LEVETIRACETAM

Application Number

78042

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78042

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2009-01-15

78042 / 2

Active Ingredient

LEVETIRACETAM

Application Number

78042

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78042

Drug Name

LEVETIRACETAM

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2009-01-15

78042 / 3

Active Ingredient

LEVETIRACETAM

Application Number

78042

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78042

Drug Name

LEVETIRACETAM

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2009-01-15

78042 / 4

Active Ingredient

LEVETIRACETAM

Application Number

78042

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78582

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2009-01-15

78582 / 1

Active Ingredient

LEVETIRACETAM

Application Number

78582

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2009-01-15

Regulatory Status

Discontinued

2023
20 Nov
Discontinued Application: 214673

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2023-11-20

214673 / 1

Active Ingredient

LEVETIRACETAM

Application Number

214673

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2023-11-20

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2002-07-01

76071 / 1

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2002-07-01

76071 / 2

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2002-07-01

76071 / 3

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2002-07-01

76071 / 4

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2002-07-01

76071 / 5

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2002
01 Jul
Discontinued Application: 76071

Drug Name

LISINOPRIL

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2002-07-01

76071 / 6

Active Ingredient

LISINOPRIL

Application Number

76071

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2002-07-01

Regulatory Status

Discontinued

2017
23 May
Discontinued Application: 202350

Drug Name

MEMANTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-05-23

202350 / 1

Active Ingredient

MEMANTINE HYDROCHLORIDE

Application Number

202350

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-05-23

Regulatory Status

Discontinued

2017
23 May
Discontinued Application: 202350

Drug Name

MEMANTINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2017-05-23

202350 / 2

Active Ingredient

MEMANTINE HYDROCHLORIDE

Application Number

202350

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2017-05-23

Regulatory Status

Discontinued

1985
29 Jan
Discontinued Application: 70039

Drug Name

METRONIDAZOLE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

1985-01-29

70039 / 1

Active Ingredient

METRONIDAZOLE

Application Number

70039

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

1985-01-29

Regulatory Status

Discontinued

1985
29 Jan
Discontinued Application: 70040

Drug Name

METRONIDAZOLE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

1985-01-29

70040 / 1

Active Ingredient

METRONIDAZOLE

Application Number

70040

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

1985-01-29

Regulatory Status

Discontinued

2012
22 May
Discontinued Application: 78195

Drug Name

NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2012-05-22

78195 / 1

Active Ingredient

NEVIRAPINE

Application Number

78195

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2012-05-22

Regulatory Status

Discontinued

2018
29 Jan
Discontinued Application: 210077

Drug Name

NYSTATIN AND TRIAMCINOLONE ACETONIDE

Product Number

1

Dosage Form

-

Strength

100,000 UNITS/GM;0.1%

Approval Date

2018-01-29

210077 / 1

Active Ingredient

NYSTATIN; TRIAMCINOLONE ACETONIDE

Application Number

210077

Product Number

1

Dosage Form

-

Strength

100,000 UNITS/GM;0.1%

Approval Date

2018-01-29

Regulatory Status

Discontinued

2003
29 May
Discontinued Application: 75876

Drug Name

OMEPRAZOLE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2003-05-29

75876 / 1

Active Ingredient

OMEPRAZOLE

Application Number

75876

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2003-05-29

Regulatory Status

Discontinued

2003
29 May
Discontinued Application: 75876

Drug Name

OMEPRAZOLE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2003-05-29

75876 / 2

Active Ingredient

OMEPRAZOLE

Application Number

75876

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2003-05-29

Regulatory Status

Discontinued

2009
21 Jan
Discontinued Application: 75876

Drug Name

OMEPRAZOLE

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2009-01-21

75876 / 3

Active Ingredient

OMEPRAZOLE

Application Number

75876

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2009-01-21

Regulatory Status

Discontinued

2002
27 Nov
Discontinued Application: 76061

Drug Name

PERGOLIDE MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 0.05MG BASE

Approval Date

2002-11-27

76061 / 1

Active Ingredient

PERGOLIDE MESYLATE

Application Number

76061

Product Number

1

Dosage Form

-

Strength

EQ 0.05MG BASE

Approval Date

2002-11-27

Regulatory Status

Discontinued

2002
27 Nov
Discontinued Application: 76061

Drug Name

PERGOLIDE MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2002-11-27

76061 / 2

Active Ingredient

PERGOLIDE MESYLATE

Application Number

76061

Product Number

2

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2002-11-27

Regulatory Status

Discontinued

2002
27 Nov
Discontinued Application: 76061

Drug Name

PERGOLIDE MESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2002-11-27

76061 / 3

Active Ingredient

PERGOLIDE MESYLATE

Application Number

76061

Product Number

3

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2002-11-27

Regulatory Status

Discontinued

2017
20 Jun
Discontinued Application: 206136

Drug Name

PIROXICAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2017-06-20

206136 / 1

Active Ingredient

PIROXICAM

Application Number

206136

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2017-06-20

Regulatory Status

Discontinued

2017
20 Jun
Discontinued Application: 206136

Drug Name

PIROXICAM

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-06-20

206136 / 2

Active Ingredient

PIROXICAM

Application Number

206136

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-06-20

Regulatory Status

Discontinued

2015
08 Dec
Discontinued Application: 205549

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

8MEQ

Approval Date

2015-12-08

205549 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

205549

Product Number

1

Dosage Form

-

Strength

8MEQ

Approval Date

2015-12-08

Regulatory Status

Discontinued

2015
08 Dec
Discontinued Application: 205549

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2015-12-08

205549 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

205549

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2015-12-08

Regulatory Status

Discontinued

2019
22 Jan
Discontinued Application: 206881

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

8MEQ

Approval Date

2019-01-22

206881 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

206881

Product Number

1

Dosage Form

-

Strength

8MEQ

Approval Date

2019-01-22

Regulatory Status

Discontinued

2019
22 Jan
Discontinued Application: 206881

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2019-01-22

206881 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

206881

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2019-01-22

Regulatory Status

Discontinued

2019
17 Jun
Discontinued Application: 210097

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

10MEQ

Approval Date

2019-06-17

210097 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

210097

Product Number

1

Dosage Form

-

Strength

10MEQ

Approval Date

2019-06-17

Regulatory Status

Discontinued

2022
17 Nov
Discontinued Application: 211665

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2022-11-17

211665 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

211665

Product Number

1

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2022-11-17

Regulatory Status

Discontinued

2024
16 Jan
Discontinued Application: 211665

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2024-01-16

211665 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

211665

Product Number

2

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2024-01-16

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2024-01-24

209883 / 1

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2024-01-24

209883 / 2

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2024-01-24

209883 / 3

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2024-01-24

209883 / 4

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2024-01-24

209883 / 5

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2024-01-24

209883 / 6

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2024-01-24

209883 / 7

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2024
24 Jan
Discontinued Application: 209883

Drug Name

PREGABALIN

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2024-01-24

209883 / 8

Active Ingredient

PREGABALIN

Application Number

209883

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2024-01-24

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2023-04-26

215755 / 1

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2023-04-26

215755 / 2

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2023-04-26

215755 / 3

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-04-26

215755 / 4

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2023-04-26

215755 / 5

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2023-04-26

215755 / 6

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2023-04-26

215755 / 7

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2023
26 Apr
Discontinued Application: 215755

Drug Name

PREGABALIN

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2023-04-26

215755 / 8

Active Ingredient

PREGABALIN

Application Number

215755

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2023-04-26

Regulatory Status

Discontinued

2017
30 Jun
Discontinued Application: 209177

Drug Name

PROMETHAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2017-06-30

209177 / 1

Active Ingredient

PROMETHAZINE HYDROCHLORIDE

Application Number

209177

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2017-06-30

Regulatory Status

Discontinued

2017
30 Jun
Discontinued Application: 209177

Drug Name

PROMETHAZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2017-06-30

209177 / 2

Active Ingredient

PROMETHAZINE HYDROCHLORIDE

Application Number

209177

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2017-06-30

Regulatory Status

Discontinued

2017
30 Jun
Discontinued Application: 209177

Drug Name

PROMETHAZINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2017-06-30

209177 / 3

Active Ingredient

PROMETHAZINE HYDROCHLORIDE

Application Number

209177

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2017-06-30

Regulatory Status

Discontinued

2011
28 Jun
Discontinued Application: 200536

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2011-06-28

200536 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

200536

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2011-06-28

Regulatory Status

Discontinued

2012
29 Feb
Discontinued Application: 201745

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2012-02-29

201745 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

201745

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2012-02-29

Regulatory Status

Discontinued

2016
22 Aug
Discontinued Application: 205512

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2016-08-22

205512 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

205512

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2016-08-22

Regulatory Status

Discontinued

2016
22 Aug
Discontinued Application: 205512

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2016-08-22

205512 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

205512

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2016-08-22

Regulatory Status

Discontinued

2018
05 Mar
Discontinued Application: 209160

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2018-03-05

209160 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

209160

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2018-03-05

Regulatory Status

Discontinued

2018
22 Feb
Discontinued Application: 209161

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-02-22

209161 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

209161

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-02-22

Regulatory Status

Discontinued

2018
01 Aug
Discontinued Application: 210010

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-01

210010 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210010

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-01

Regulatory Status

Discontinued

2018
01 Aug
Discontinued Application: 210010

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-08-01

210010 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210010

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-08-01

Regulatory Status

Discontinued

2019
11 Feb
Discontinued Application: 210346

Drug Name

TRIAMCINOLONE ACETONIDE

Product Number

1

Dosage Form

-

Strength

0.025%

Approval Date

2019-02-11

210346 / 1

Active Ingredient

TRIAMCINOLONE ACETONIDE

Application Number

210346

Product Number

1

Dosage Form

-

Strength

0.025%

Approval Date

2019-02-11

Regulatory Status

Discontinued

2019
11 Feb
Discontinued Application: 210346

Drug Name

TRIAMCINOLONE ACETONIDE

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

2019-02-11

210346 / 2

Active Ingredient

TRIAMCINOLONE ACETONIDE

Application Number

210346

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

2019-02-11

Regulatory Status

Discontinued

2019
11 Feb
Discontinued Application: 210346

Drug Name

TRIAMCINOLONE ACETONIDE

Product Number

3

Dosage Form

-

Strength

0.5%

Approval Date

2019-02-11

210346 / 3

Active Ingredient

TRIAMCINOLONE ACETONIDE

Application Number

210346

Product Number

3

Dosage Form

-

Strength

0.5%

Approval Date

2019-02-11

Regulatory Status

Discontinued

2007
23 Apr
Discontinued Application: 76062

Drug Name

ZOLPIDEM TARTRATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-04-23

76062 / 1

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

76062

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-04-23

Regulatory Status

Discontinued

2007
23 Apr
Discontinued Application: 76062

Drug Name

ZOLPIDEM TARTRATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-04-23

76062 / 2

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

76062

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-04-23

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    227 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
103 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Application Number

86366

Product Number

1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit